FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Travere Expecting 3-month NDA Review Extension

[ Price : $8.95]

Travere Therapeutics says it is expecting FDA to extend its review by three months of an accelerated approval-seeking NDA for spar...

Revive Therapeutics Amends Protocol on Covid Therapy

[ Price : $8.95]

Revive Therapeutics finalizes an amended protocol for the companys Phase 3 clinical trial designed to evaluate the safety and effi...

FDA Accepts BioMarin BLA for Gene Therapy

[ Price : $8.95]

FDA accepts for review a BioMarin BLA resubmission for gene therapy valoctocogene roxaparvovec for adults with severe hemophilia A...

Agency Seeks Consumer Reps on Advisory Committees

[ Price : $8.95]

Federal Register notice: FDA seeks consumer organizations that are interested in participating in selecting voting and nonvoting c...

Dietary Supplement GMPs Info Collection

[ Price : $8.95]

Federal Register notice: FDA seeks comments on an information collection extension entitled Current Good Manufacturing Practice in...

CMS Working with FDA on New Device Coverage Rule

[ Price : $8.95]

Two Centers for Medicare and Medicaid Services officials describe the principles in a new coverage rule for innovative medical dev...

Exela Pharma Recalls 49 Sodium Bicarbonate Lots

[ Price : $8.95]

Exela Pharma Sciences (Lenoir, NC) recalls 49 lots of sodium bicarbonate injection due to safety concerns.

FDA Revamping NDA/BLA Information Requests

[ Price : $8.95]

FDA seeks public comments on a Statement of Work mandated by the recent drug user fee reauthorization to assess communication betw...

Three Charged with Falsifying Clinical Trial Data

[ Price : $8.95]

A Miami grand jury charges three defendants for their roles in an alleged scheme to fabricate and falsify clinical drug trial data...

FDA Publishes ICH E19 Guideline

[ Price : $8.95]

FDA publishes the International Council for Harmonization E19 guideline on selective safety data collection in some circumstances.